Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

---

Atıf İçin Kopyala

Sünnetçioğlu M., Mengeloglu Z., Baran A. İ., Karahocagil M., Tosun M., Kucukbayrak A., ...Daha Fazla

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, cilt.13, 2014 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 13
• Basım Tarihi: 2014
• Doi Numarası: 10.1186/1476-0711-13-12
• Dergi Adı: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Background: Asymmetric dimethylarginine (ADMA), the main endogenous inhibitor of nitric oxide synthase, is considered to be associated with endothelial dysfunction. High ADMA levels have been shown to be related with disorders causing vascular inflammation such as hypertension, hypercholesterolemia, atherosclerosis, chronic heart failure, stroke and sepsis. Cutaneous anthrax (CA) is a serious infectious disease which may cause vasculitis. The aim of the study was to investigate the serum ADMA levels in patients with CA.